The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

AstraZeneca PLC

NYSE: AZN
Last

(U.S.) $34.62

Today's change-0.09 -0.26%
Updated October 20 4:02 PM EDT. Delayed by at least 15 minutes.
 

AstraZeneca PLC

NYSE: AZN
Last

(U.S.) $34.62

Today's change-0.09 -0.26%
Updated October 20 4:02 PM EDT. Delayed by at least 15 minutes.

AstraZeneca PLC down (U.S.)$0.09

AstraZeneca PLC closed lower Friday, dropping (U.S.)$0.09 or 0.26% to (U.S.)$34.62. Over the last five days, shares are unchanged, but are currently 2.75% below its 52-week high. This security has underperformed the S&P 500 by 8.58% during the last year.

Key company metrics

  • Open(U.S.) $34.77
  • Previous close(U.S.) $34.71
  • High(U.S.) $34.81
  • Low(U.S.) $34.53
  • Bid / Ask-- / --
  • YTD % change+26.72%
  • Volume2,302,108
  • Average volume (10-day)3,489,411
  • Average volume (1-month)4,641,988
  • Average volume (3-month)4,866,591
  • 52-week range(U.S.) $25.55 to (U.S.) $35.60
  • Beta0.73
  • Trailing P/E22.65×
  • P/E 1 year forward18.21×
  • Forward PEG2.46×
  • Indicated annual dividend(U.S.) $1.40
  • Dividend yield4.04%
  • Trailing EPS(U.S.) $1.53
Updated October 20 4:02 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue5,0515,4055,5855,699
Total other revenue--------
Total revenue5,0515,4055,5855,699
Gross profit4,1444,5494,4684,858
Total cost of revenue9078561,117841
Total operating expense4,1264,4883,0524,671
Selling / general / administrative2,0401,9292,1331,968
Research & development1,2791,3381,4811,337
Depreciation / amortization310284298297
Interest expense (income), net operating--------
Unusual expense (income)215414-835335
Other operating expenses, total-625-333-1,142-107
Operating income9259172,5331,028
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax4925822,183676
Income after tax4465121,817995
Income tax, total4670366-319
Net income4775371,8421,014
Total adjustments to net income--------
Net income before extra. items4775371,8421,014
Minority interest31252519
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items4775371,8421,014
Inc. avail. to common incl. extra. items4775371,8421,014
Diluted net income4775371,8421,014
Dilution adjustment0--00
Diluted weighted average shares1,2671,2661,2661,266
Diluted EPS excluding extraordinary itemsvalue per share0.380.421.450.80
Dividends per sharevalue per share0.900.00--0.00
Diluted normalized EPSvalue per share0.530.711.151.07